Digipath Labs Cannabis Testing News

Las Vegas Cannabis Testing News and More

New DEA Policy Developments with Regard to Cannabidiol

1
New DEA Policy Developments with Regard to Cannabidiol

As we impatiently await dispatch from the forthcoming administration in Washington as to their interpretation of the current state of cannabis access across the U.S., the DEA quietly published an item, 21 CFR Part 1308, in the Federal Register on December 14th.  The notice establishes a new drug code 7350 under Schedule I for “marihuana […]

Read More

Curtailment In Oregon’s Cannabis Market

Curtailment In Oregon’s Cannabis Market

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs The news of Oregon’s cannabis market coming to its knees because of strict testing requirements casts a long shadow on those states faced with rolling out newly voter-approved MMJ or retail cannabis programs.  One can easily conclude from the rising national awareness of the prevalence of tainted cannabis […]

Read More

Cannabis Use Disorder

1
Cannabis Use Disorder

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs ‘Cannabis Use Disorder,’ or CUD for short is described as a new mental health condition categorized in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the diagnostic bible of psychiatrists.  The DSM publication is used by clinicians, researchers, drug regulatory agencies, health insurance […]

Read More

When Retail Marijuana Competes with Medical Marijuana

When Retail Marijuana Competes with Medical Marijuana

By Cindy Orser, PhD, Chief Science Officer of Digipath Labs  On November 8th the citizens of five states, Nevada, California, Maine, Arizona and Massachusetts, all with existing medical marijuana (MMJ) programs will be voting on the legalization of recreational marijuana. These states could be joining Alaska, Washington, Oregon, Colorado and the District of Columbia with dueling marijuana programs […]

Read More

DigiPath Labs Validates New Extraction Technology

3
DigiPath Labs Validates New Extraction Technology

Yahoo Finance reports: LAS VEGAS, NV–(Marketwired – Oct 20, 2016) – DigiPath Labs, a subsidiary of DigiPath, Inc. ( OTCQB : DIGP ), an independent cannabis testing lab and media firm, recently completed a successful validation of Fluid Management Systems’ (FMS) pressure liquid extractor (PLEâ) for use across four different cannabis matrices. The extraction methods […]

Read More

Toward A Sampling Plan For Cannabis

Toward A Sampling Plan For Cannabis

By Cindy Orser | Chief Science Officer There are two major considerations in determining a sampling strategy for a cannabis harvest or production batch: 1) the number of samples to be taken from a defined unit test batch, harvest or production; and, 2) the amount (mass) of each of those samples and whether they are […]

Read More

UK Halts CBD Sales

UK Halts CBD Sales

By Cindy Orser | Chief Science Officer   A significant event occurred in the UK last week for the cannabis world as we currently know it.  The UK’s equivalent to our FDA, the Medicine and Healthcare Products Regulatory Agency (MJRA), sent out letters to cannabidiol (CBD) producers and distributors ordering them to stop selling, promoting, […]

Read More

Digipath Labs Is Giving Back To Patients

Digipath Labs Is Giving Back To Patients

By: Stephanie Shehan | Vegas Cannabis Magazine CURRENTLY, PATIENTS HAVE THE ABILITY TO WALK INTO A LOCAL CANNABIS DISPENSARY AND PURCHASE SAFE, LAB-TESTED PRODUCTS. THIS IS SOMETHING THAT THOSE IN NON-MEDICAL STATES DO NOT HAVE THE ABILITY TO PARTAKE IN. Digipath Labs has announced they will be giving FREE testing for Nevada medical marijuana patients that grow their […]

Read More